35.17
price up icon0.57%   0.20
after-market Dopo l'orario di chiusura: 35.09 -0.08 -0.23%
loading
Precedente Chiudi:
$34.97
Aprire:
$35.86
Volume 24 ore:
412.36K
Relative Volume:
0.37
Capitalizzazione di mercato:
$4.39B
Reddito:
$418.33M
Utile/perdita netta:
$-252.07M
Rapporto P/E:
-14.65
EPS:
-2.4
Flusso di cassa netto:
$-238.84M
1 W Prestazione:
-6.41%
1M Prestazione:
+16.69%
6M Prestazione:
+34.29%
1 anno Prestazione:
+103.41%
Intervallo 1D:
Value
$34.81
$36.00
Intervallo di 1 settimana:
Value
$34.55
$37.10
Portata 52W:
Value
$16.01
$44.34

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name
Nome
Zai Lab Limited Adr
Name
Telefono
862161632588
Name
Indirizzo
4560 JINKE ROAD, SHANGHAI
Name
Dipendente
1,844
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
ZLAB's Discussions on Twitter

Confronta ZLAB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ZLAB
Zai Lab Limited Adr
35.17 4.39B 418.33M -252.07M -238.84M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-07 Iniziato Scotiabank Sector Outperform
2025-03-03 Downgrade BofA Securities Buy → Neutral
2023-12-14 Iniziato Morgan Stanley Overweight
2023-08-10 Iniziato Cantor Fitzgerald Overweight
2022-01-21 Iniziato Macquarie Outperform
2021-10-12 Iniziato Bernstein Mkt Perform
2020-04-28 Iniziato Goldman Buy
2020-04-15 Iniziato Guggenheim Buy
2019-07-12 Iniziato BofA/Merrill Buy
2019-07-05 Iniziato Macquarie Outperform
2019-01-29 Iniziato Credit Suisse Outperform
2018-11-21 Iniziato Jefferies Buy
2018-06-21 Ripresa Leerink Partners Outperform
2018-02-14 Aggiornamento JP Morgan Neutral → Overweight
2017-10-16 Iniziato JP Morgan Neutral
2017-10-16 Iniziato Leerink Partners Outperform
Mostra tutto

Zai Lab Limited Adr Borsa (ZLAB) Ultime notizie

pulisher
Jun 18, 2025

Metric Deep Dive: Understanding Winnebago Industries, Inc (WGO) Through its Ratios - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Zai Lab Limited ADR (ZLAB) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jun 18, 2025
pulisher
Jun 16, 2025

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Jun 16, 2025
pulisher
Jun 12, 2025

Zai Lab Limited ADR (ZLAB) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

CarParts.com Inc (PRTS) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jun 12, 2025
pulisher
Jun 10, 2025

Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize

Jun 10, 2025
pulisher
Jun 09, 2025

Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Trims Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Has $1.63 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus

Jun 04, 2025
pulisher
Jun 01, 2025

Zai Lab Limited (NASDAQ:ZLAB) Sees Large Drop in Short Interest - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance

May 31, 2025
pulisher
May 31, 2025

What Analysts Were Expecting After Zai Lab Limited ADR (NASDAQ: ZLAB) fell -3.74% - Stocksregister

May 31, 2025
pulisher
May 30, 2025

Zai Lab Announces Participation in Investor Conferences in June 2025 - BioSpace

May 30, 2025
pulisher
May 30, 2025

Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan

May 30, 2025
pulisher
May 28, 2025

Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 28, 2025
pulisher
May 27, 2025

Quantinno Capital Management LP Reduces Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 27, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Purchases 18,472 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 25, 2025
pulisher
May 19, 2025

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace

May 19, 2025
pulisher
May 15, 2025

Barclays PLC Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Increased Earnings for Zai Lab - Defense World

May 15, 2025
pulisher
May 13, 2025

Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 11, 2025

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN

May 11, 2025
pulisher
May 09, 2025

Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 07, 2025

Trading Day Triumph: Zai Lab Limited ADR (ZLAB) Ends at 29.38, a -5.07 Surge/Plunge - DWinneX

May 07, 2025
pulisher
May 05, 2025

Raymond James Financial Inc. Makes New $1.03 Million Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 05, 2025
pulisher
May 02, 2025

Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Invesco Ltd. - Defense World

May 02, 2025
pulisher
May 02, 2025

Envestnet Asset Management Inc. Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 02, 2025
pulisher
May 01, 2025

Geode Capital Management LLC Boosts Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Post-Trade Analysis: VICI Properties Inc (VICI) Climbs 0.06, Closing at 32.26 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Market Insights: Canadian Solar Inc (CSIQ)’s Notable Drop of -1.73, Closing at 9.65 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Daily Market Movement: Faraday Future Intelligent Electric Inc (FFAI) Sees a -0.76 Decrease, Closing at 1.30 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

In the Green: Zai Lab Limited ADR (ZLAB) Closes at 31.84, Up/Down -1.82 from Previous Day - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Closing Bell Recap: C.H. Robinson Worldwide, Inc (CHRW) Ends at 88.33, Reflecting a -0.84 Downturn - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Zai Lab Limited ADR (ZLAB) is looking forward to a strong quarter - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Wells Fargo & Company MN Grows Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Zai Lab Ltd Announces 2025 Annual General Meeting - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Zai Lab Limited ADR (ZLAB) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Apr 29, 2025
pulisher
Apr 25, 2025

Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025 - Business Wire

Apr 25, 2025
pulisher
Apr 24, 2025

Ratios Reveal: Breaking Down Packaging Corp Of America (PKG)’s Financial Health - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Analytical Overview: GE Vernova Inc (GEV)’s Ratios Tell a Financial Story - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Health Check: Examining Bellring Brands Inc (BRBR)’s Key Ratios - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Deeper Dive: Understanding Concentrix Corp (CNXC) Through its Various Ratios - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

A stock that deserves closer examination: Zai Lab Limited ADR (ZLAB) - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Ratios Reveal: Breaking Down Check Point Software Technologies Ltd (CHKP)’s Financial Health - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Metrics Unveiled: Orchestra BioMed Holdings Inc (OBIO)’s Key Ratios in the Spotlight - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Ratios in Focus: Analyzing Watsco Inc (WSO)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Theratechnologies Inc (THTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

Apr 24, 2025

Zai Lab Limited Adr Azioni (ZLAB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Zai Lab Limited Adr Azioni (ZLAB) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Du Ying
Chairperson & CEO
Jun 26 '25
Sale
36.13
23,669
855,208
514,982
Chen Yajing
Chief Financial Officer
Jun 26 '25
Sale
36.13
2,675
96,653
21,004
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):